ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 90 locations in 37 countries and has approximately 13,680 employees.

Authors

Sheila Kelly

Commercial Director, Information Technology

Sheila holds the post of Director, Commercial Affairs at ICON plc, a specialist clinical research organisation (CRO) that conducts clinical research on behalf of the pharmaceutical and biotechnology i...

Jamie Tallon

Director, Product Innovation � ICON

Jamie is Director of Product Innovation at ICON and has more than 15 years’ experience in the CRO environment and began his career in Data Management, leading the protocol interpretation, CRF and eC...

❮ ❯

Articles

4027

Data Collection in Phase II-III Clinical Research ...

3394

A collaborative approach to innovation in Pharma...